Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Validation of HPLC and TLC analytical methods to determine radiochemical purity of 99mTc-cAbVCAM1-5, a new experimental radiotracer

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Université Grenoble Alpes - UFR Pharmacie (UGA UFRP); Université Grenoble Alpes (UGA); Département de pharmacochimie moléculaire (DPM); Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA); Radiopharmaceutiques biocliniques (LRB); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes (UGA); Translational Innovation in Medicine and Complexity / Recherche Translationnelle et Innovation en Médecine et Complexité - UMR 5525 (TIMC); VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP); Centre Hospitalier Universitaire CHU Grenoble (CHUGA); ANR-13-PRTS-0019,MC2,Imagerie moléculaire des plaques d'athérome coronaires en pratique clinique(2013)
    • بيانات النشر:
      HAL CCSD
      Elsevier
    • الموضوع:
      2024
    • Collection:
      Université Grenoble Alpes: HAL
    • نبذة مختصرة :
      International audience ;  99m Tc-cAbVCAM1-5 is a new experimental radiotracer targeting a marker of inflammation found in vulnerable atheromatous plaques in cardiac diseases.  In order to complete an investigational medicinal product dossier, a validation of the analytical method New radiotracer requires validation of analytical method to assess radiochemical purity by HPLC and TLC is required.  Specificity, accuracy, repeatability and intermediate precision, linearity, robustness, quantification limit (LoQ), and range criteria were assessed for HPLC and TLC method.  The results developed in this study show that the analytical method is particularly suitable for assessing the radiochemical purity of 99m Tc-cAbVCAM1-5 in our laboratory. ABSTRACT Cardiovascular diseases, including fatal myocardial infarctions from atheromatous plaques, are the primary global mortality cause. Detecting stenotic atheromatous plaques is possible through coronary angiography, but vulnerable plaques with eccentric remodeling are undetectable with current diagnostic methods. Addressing this challenge, our group developed a radiopharmaceutical drug targeting Vvascular Ccell Aadhesion Mmolecule 1 (VCAM-1), radiolabeled with technetium-99m. Given the absence of a monograph in the European Pharmacopoeia, and in order to draft the investigational medicinal product documentation, analytical methods had to be validated by Hhigh Pperformance Lliquid Cchromatography (HPLC) and Tthin Llayer Cchromatography (TLC) to determine the radiochemical purity (RCP) of 99m Tc-cAbVCAM1-5. This study therefore presents the results of the validation of analytical methods obtained in this context. The method validation followed the European Association of Nuclear Medicine (EANM) recommendations adapted from ICH Q2(R1), ensuring conformity with specificity, accuracy, repeatability and intermediate precision, linearity, robustness, quantification limit (LoQ), and range criteria. Regarding the results of specificity, both HPLC and TLC methods demonstrated ...
    • الرقم المعرف:
      10.1016/j.jpba.2024.116224
    • الدخول الالكتروني :
      https://hal.science/hal-04776949
      https://hal.science/hal-04776949v1/document
      https://hal.science/hal-04776949v1/file/Manuscript_JPBA_review_v3.pdf
      https://doi.org/10.1016/j.jpba.2024.116224
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.5E8F5FB5